CUV — Clinuvel Pharmaceuticals Share News
0.000.00%
Last trade - 00:00- AU$381.23m
- AU$131.12m
- AU$94.02m
Australia Stock Exchange release from CLINUVEL PHARMAC : Progress update to DNA Repair Program
Australia Stock Exchange release from CLINUVEL PHARMAC : Chair Letter
Clinuvel Pharma jumps as FDA allows phase II study for skin disorder treatment
Australia Stock Exchange release from CLINUVEL PHARMAC : CLINUVEL Newsletter 6 - December 2021
Australia Stock Exchange release from CLINUVEL PHARMAC : CLINUVEL Study to Evaluate SCENESSE as Vitiligo Monotherapy
Australia Stock Exchange release from CLINUVEL PHARMAC : CLINUVEL Newsletter 5 - November 2021
Australia Stock Exchange release from CLINUVEL PHARMAC : Presentation Jefferies London Healthcare Conference
Australia Stock Exchange release from CLINUVEL PHARMAC : Results of Meeting
Australia Stock Exchange release from CLINUVEL PHARMAC : Managing Director AGM Presentation
Australia Stock Exchange release from CLINUVEL PHARMAC : Chair Address
Australia Stock Exchange release from CLINUVEL PHARMAC : CLINUVEL Strategic Update III - November 2021
Brief: Clinuvel Pharmaceuticals Reached Longer Term Commercial Deal For Supply Of Hormone Drug
Australia Stock Exchange release from CLINUVEL PHARMAC : Media release - CLINUVEL Expands Pharmaceutical Portfolio
Australia Stock Exchange release from CLINUVEL PHARMAC : CLINUVEL adds ACTH to portfolio
Australia Stock Exchange release from CLINUVEL PHARMAC : Response to ASX Price Query
Australia Stock Exchange release from CLINUVEL PHARMAC : PRE_NR Ends: 09:16:06
Australia's Clinuvel sinks as Jefferies sees threat from Japanese skin drug
Australia Stock Exchange release from CLINUVEL PHARMAC : PRE_NR Ends: 09:39:06
Australia Stock Exchange release from CLINUVEL PHARMAC : Quarterly Activities/Appendix 4C Cash Flow Report